GlassScriptPhysician profile
Brooke Ashley Moore
NPI 1760168975
$1,984.57
in general payments reported to CMS, 2019-2025
16 companies · $897 in 2025
The $897 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,088 · 2025: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,984.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $760.83 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $212.28 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Medtronic, INC. | $151.45 | 2024 | Reveal Linq |
| Abbvie INC. | $137.05 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $125.31 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $116.40 | 2024-2025 | |
| Corcept Therapeutics | $113.03 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $90.73 | 2024-2025 | |
| Amgen INC. | $70.71 | 2025 | Otezla, Repatha |
| Astellas Pharma US INC | $68.44 | 2024-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.89 | 2024-2025 | Jardiance |
| Esperion Therapeutics, INC. | $34.69 | 2024 | Nexletol |
| Boston Scientific Corporation | $19.04 | 2025 | Overstitch Endoscopic Suturing System |
| Kowa Pharmaceuticals America, INC. | $15.51 | 2025 | Zoryve |
| Phadia US INC. | $15.11 | 2024 | Immunocap |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.10 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.